Peptide Dosing Protocols does not directly sell NAD+
Studied in models involving ERR signaling, mitochondrial output, exercise-mimetic pathways, and metabolic adaptation
Our goal is to expand COA access across the full catalog as production capacity grows
Researchers are also investigating cyclodextrin-based formulations that respond to specific stimuli such as pH, temperature, light, or enzymatic activity
HUBERMAN: So if you have a tumor someplace and it's small, taking exogenous growth hormone or increasing the amount of growth hormone that you release by taking one of these peptides that we discussed will increase the size of that tumor
The announcement removes enforcement risk, so pharmacies that previously declined to compound BPC-157 may now be willing